• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转座子工具:全球知识产权与技术发展态势

Transposon tools: worldwide landscape of intellectual property and technological developments.

作者信息

Palazzoli Fabien, Testu François-Xavier, Merly Franck, Bigot Yves

机构信息

UFR des Sciences & Techniques, Université François Rabelais de Tours, GICC, Tours, France.

出版信息

Genetica. 2010 Mar;138(3):285-99. doi: 10.1007/s10709-009-9426-3. Epub 2009 Dec 3.

DOI:10.1007/s10709-009-9426-3
PMID:19957019
Abstract

DNA transposons are considered to be good candidates for developing tools for genome engineering, insertional mutagenesis and gene delivery for therapeutic purposes, as illustrated by the recent first clinical trial of a transposon. In this article we set out to highlight the interest of patent information, and to develop a strategy for the technological development of transposon tools, similar to what has been done in many other fields. We propose a patent landscape for transposon tools, including the changes in international patent applications, and review the leading inventors and applicants. We also provide an overview of the potential patent portfolio for the prokaryotic and eukaryotic transposons that are exploited by spin-off companies. Finally, we discuss the difficulties involved in tracing relevant state-of-the-art of articles and patent documents, based on the example of one of the most promising transposon systems, including all the impacts on the technological development of transposon tools.

摘要

DNA转座子被认为是开发用于基因组工程、插入诱变和治疗性基因传递工具的理想候选者,最近一项转座子的首次临床试验就证明了这一点。在本文中,我们旨在突出专利信息的重要性,并制定一种转座子工具技术开发策略,类似于许多其他领域所采用的方法。我们提出了转座子工具的专利格局,包括国际专利申请的变化,并回顾了主要的发明人和申请人。我们还概述了衍生公司所利用的原核和真核转座子的潜在专利组合。最后,我们以最有前景的转座子系统之一为例,讨论追踪相关文章和专利文献现有技术的困难,以及这对转座子工具技术开发的所有影响。

相似文献

1
Transposon tools: worldwide landscape of intellectual property and technological developments.转座子工具:全球知识产权与技术发展态势
Genetica. 2010 Mar;138(3):285-99. doi: 10.1007/s10709-009-9426-3. Epub 2009 Dec 3.
2
The Sleeping Beauty transposon toolbox.睡美人转座子工具箱。
Methods Mol Biol. 2012;859:229-40. doi: 10.1007/978-1-61779-603-6_13.
3
Transposon-mediated genome manipulation in vertebrates.转座子介导的脊椎动物基因组操作。
Nat Methods. 2009 Jun;6(6):415-22. doi: 10.1038/nmeth.1332.
4
Jump around: transposons in and out of the laboratory.跳跃不止:实验室内外的转座子
F1000Res. 2020 Feb 24;9. doi: 10.12688/f1000research.21018.1. eCollection 2020.
5
Transposons: Moving Forward from Preclinical Studies to Clinical Trials.转座子:从临床前研究迈向临床试验。
Hum Gene Ther. 2017 Nov;28(11):1087-1104. doi: 10.1089/hum.2017.128. Epub 2017 Aug 22.
6
Transposon-based vector systems for gene therapy clinical trials: challenges and considerations.用于基因治疗临床试验的基于转座子的载体系统:挑战与考量
Chang Gung Med J. 2011 Nov-Dec;34(6):565-79.
7
Proposed uses of transposons in insect and medical biotechnology.转座子在昆虫和医学生物技术中的潜在应用。
Adv Exp Med Biol. 2008;627:60-70. doi: 10.1007/978-0-387-78225-6_5.
8
Generating and manipulating transgenic animals using transposable elements.利用转座元件生成和操控转基因动物。
Reprod Biol Endocrinol. 2003 Nov 7;1:80. doi: 10.1186/1477-7827-1-80.
9
Preclinical and clinical advances in transposon-based gene therapy.基于转座子的基因治疗的临床前和临床进展。
Biosci Rep. 2017 Dec 5;37(6). doi: 10.1042/BSR20160614. Print 2017 Dec 22.
10
An Overview on Indian Patents on Biotechnology.印度生物技术专利概述
Recent Pat Biotechnol. 2015;9(3):198-213. doi: 10.2174/1872208310666160325113553.

引用本文的文献

1
Modulating signaling networks by CRISPR/Cas9-mediated transposable element insertion.通过CRISPR/Cas9介导的转座元件插入来调控信号网络。
Curr Genet. 2018 Apr;64(2):405-412. doi: 10.1007/s00294-017-0765-9. Epub 2017 Oct 14.
2
The Drosophila mojavensis Bari3 transposon: distribution and functional characterization.荒漠棒眼果蝇 Bari3 转座子的分布与功能特征。
Mob DNA. 2014 Jul 8;5:21. doi: 10.1186/1759-8753-5-21. eCollection 2014.
3
Optimization of the piggyBac transposon using mRNA and insulators: toward a more reliable gene delivery system.

本文引用的文献

1
Bacterial genetic methods to explore the biology of mariner transposons.探索水手转座子生物学特性的细菌遗传学方法。
Genetica. 2010 May;138(5):499-508. doi: 10.1007/s10709-009-9401-z. Epub 2009 Aug 27.
2
Proprietary science, open science and the role of patent disclosure: the case of zinc-finger proteins.专有科学、开放科学与专利披露的作用:以锌指蛋白为例
Nat Biotechnol. 2009 Feb;27(2):140-4. doi: 10.1038/nbt0209-140.
3
Gene targeting for chromosome engineering applications in eukaryotic cells.用于真核细胞染色体工程应用的基因靶向技术。
利用mRNA和绝缘子优化piggyBac转座子:构建更可靠的基因递送系统
PLoS One. 2013 Dec 3;8(12):e82559. doi: 10.1371/journal.pone.0082559. eCollection 2013.
Recent Pat Biotechnol. 2008;2(2):94-106. doi: 10.2174/187220808784619720.
4
Sustained transgene expression using non-viral enzymatic systems for stable chromosomal integration.利用非病毒酶系统实现稳定染色体整合以持续进行转基因表达。
Curr Gene Ther. 2008 Oct;8(5):367-90. doi: 10.2174/156652308786070970.
5
Sleeping beauty vector system moves toward human trials in the United States.“睡美人”载体系统在美国正朝着人体试验迈进。
Mol Ther. 2008 Sep;16(9):1515-6. doi: 10.1038/mt.2008.169.
6
Insect population suppression using engineered insects.利用基因工程昆虫抑制昆虫种群
Adv Exp Med Biol. 2008;627:93-103. doi: 10.1007/978-0-387-78225-6_8.
7
Totipotency/pluripotency and patentability.全能性/多能性与可专利性。
Stem Cells. 2008 Jun;26(6):1656-7. doi: 10.1634/stemcells.2008-0232. Epub 2008 Apr 10.
8
Patenting pluripotence: the next battle for stem cell intellectual property.为多能性申请专利:干细胞知识产权的下一场较量。
Nat Biotechnol. 2008 Apr;26(4):393-5. doi: 10.1038/nbt0408-393.
9
Mechanism of IS200/IS605 family DNA transposases: activation and transposon-directed target site selection.IS200/IS605 家族 DNA 转座酶的机制:激活与转座子导向的靶位点选择
Cell. 2008 Jan 25;132(2):208-20. doi: 10.1016/j.cell.2007.12.029.
10
DNA transposons and the evolution of eukaryotic genomes.DNA转座子与真核生物基因组的进化
Annu Rev Genet. 2007;41:331-68. doi: 10.1146/annurev.genet.40.110405.090448.